Clinical Trial Update: OM202JP Clinical Study of KNP2002 [Phase 2]

View source ↗

Summary

This is a Phase 2 trial of KNP2002 (OM202JP) by KinoPharma Inc. for common warts, which has completed. The document notes the study status as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Warts

Drugs mentioned

• KNP2002

Snippet

Sponsor: KinoPharma Inc. | Conditions: Common Wart | Phase 2 | Status: COMPLETED